<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28074" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pulseless Ventricular Tachycardia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Foglesong</surname>
            <given-names>Adam</given-names>
          </name>
          <aff>Beaumont Royal Oak</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mathew</surname>
            <given-names>Dana</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Adam Foglesong declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dana Mathew declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28074.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Pulseless ventricular tachycardia is a serious condition with high mortality and morbidity that requires prompt diagnosis and treatment. This activity reviews the etiology, evaluation, and management of pulseless ventricular tachycardia, and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the epidemiology of pulseless ventricular tachycardia.</p></list-item><list-item><p>Review the pathophysiology of pulseless ventricular tachycardia.</p></list-item><list-item><p>Outline the treatment and management options available for pulseless ventricular tachycardia.</p></list-item><list-item><p>Describe the interprofessional team strategies for improving care coordination and communication to advance pulseless ventricular tachycardia, and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28074&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28074">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28074.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pulseless ventricular tachycardia is a life-threatening cardiac arrhythmia in which coordinated ventricular contractions are replaced by very rapid but ineffective contractions, leading to insufficient organ perfusion and heart failure. Pulseless ventricular tachycardia is a medical emergency.</p>
        <p>Due to rapid ventricular contractions, the ventricular filling decreases markedly, leading to a dramatic decrease in cardiac output. As a result, a pulse is absent. Electrophysiology identifying factors&#x000a0;for pulseless ventricular tachycardia include;&#x000a0; tachycardia (&#x0003e;100 bpm), wide QRS complexes (&#x0003e; 120 milliseconds), atrioventricular (AV) dissociation, presence of fusion or capture beats and an electrical axis between -90 to -180. There are several scoring systems to differentiate ventricular tachycardia from a wide complex supraventricular tachycardia, but 90% of wide complex tachycardia cases will be ventricular tachycardia.&#x000a0;</p>
        <p>The ventricular arrhythmia can be characterized as either monomorphic (no variation of the QRS from beat to beat) or polymorphic (changing or multiform QRS from beat to beat). The most common cause of pulseless ventricular tachycardia is cardiac ischemia.<xref ref-type="bibr" rid="article-28074.r1">[1]</xref></p>
      </sec>
      <sec id="article-28074.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Pulseless ventricular tachycardia (VT) can result from a multitude of causes and predisposing conditions, including but not limited to, structural heart disease, electrolyte disturbances, drugs/medications, and congenital/inherited channelopathies.<xref ref-type="bibr" rid="article-28074.r1">[1]</xref>&#x000a0;The most common cause of ventricular tachycardia (including pulseless VT) is concomitant structural heart disease.</p>
        <p>Below are several examples organized into the following categories:</p>
        <p>Structural Heart Disease:</p>
        <list list-type="bullet">
          <list-item>
            <p>coronary artery disease</p>
          </list-item>
          <list-item>
            <p>aortic stenosis</p>
          </list-item>
          <list-item>
            <p>cardiomyopathy</p>
          </list-item>
          <list-item>
            <p>congestive heart failure</p>
          </list-item>
          <list-item>
            <p>hypertrophic obstructive cardiomyopathy (HOCM)</p>
          </list-item>
          <list-item>
            <p>myocardial infarction (MI)</p>
          </list-item>
        </list>
        <p>Electrolyte Disturbances:</p>
        <list list-type="bullet">
          <list-item>
            <p>hypokalemia</p>
          </list-item>
          <list-item>
            <p>hyperkalemia</p>
          </list-item>
          <list-item>
            <p>hypomagnesemia</p>
          </list-item>
          <list-item>
            <p>hypocalcemia</p>
          </list-item>
        </list>
        <p>Channelopathies:</p>
        <list list-type="bullet">
          <list-item>
            <p>Lange-Nielsen Syndrome (prolonged QT with deafness)</p>
          </list-item>
          <list-item>
            <p>Romano-Ward Syndrome (prolonged QT without deafness)</p>
          </list-item>
          <list-item>
            <p>Brugada Syndrome</p>
          </list-item>
        </list>
        <p>&#x000a0;Electrophysiologic Phenomena:</p>
        <list list-type="bullet">
          <list-item>
            <p>Wolf-Parkinson-White Syndrome (WPW)</p>
          </list-item>
          <list-item>
            <p>Catecholamine Sensitive Polymorphic Ventricular Tachycardia</p>
          </list-item>
        </list>
        <p>Drugs/medications that cause QT prolongation:</p>
        <list list-type="bullet">
          <list-item>
            <p>Clarithromycin</p>
          </list-item>
          <list-item>
            <p>Erythromycin</p>
          </list-item>
          <list-item>
            <p>Metoclopramide</p>
          </list-item>
          <list-item>
            <p>Haloperidol</p>
          </list-item>
          <list-item>
            <p>Methadone</p>
          </list-item>
          <list-item>
            <p>Droperidol</p>
          </list-item>
          <list-item>
            <p>Fluoroquinolone antibiotics (i.e., ciprofloxacin)</p>
          </list-item>
          <list-item>
            <p>Antiemetics (i.e., ondansetron)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Antiarrhythmics&#x000a0;</p>
          </list-item>
        </list>
        <p>Other causes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypovolemia</p>
          </list-item>
          <list-item>
            <p>Hypoxia</p>
          </list-item>
          <list-item>
            <p>Acidosis</p>
          </list-item>
          <list-item>
            <p>Hypothermia</p>
          </list-item>
          <list-item>
            <p>Tension pneumothorax</p>
          </list-item>
          <list-item>
            <p>Cardiac tamponade</p>
          </list-item>
          <list-item>
            <p>Pulmonary embolism</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28074.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Ventricular tachycardia (VT) remains a significant contributor to&#x000a0;most sudden cardiac deaths in the U.S.,&#x000a0;at an estimated rate of approximately 300000 deaths per year.<xref ref-type="bibr" rid="article-28074.r2">[2]</xref><xref ref-type="bibr" rid="article-28074.r3">[3]</xref>&#x000a0;The majority of these deaths occur in adults greater than 35 years of age, with at least half&#x000a0;attributable to ventricular arrhythmias. Estimates of its prevalence vary from 30% to 75% of out-of-hospital cardiac arrests despite recent increases in the incidence of pulseless electrical activity.<xref ref-type="bibr" rid="article-28074.r2">[2]</xref> However, the true incidence is unknown due to inevitable degeneration to asystole if unwitnessed.&#x000a0;Despite the decline in coronary artery disease mortality and advancements in resuscitation services, survival from these events remains low, especially if occurring outside the hospital environment, with an associated survival rate of less than 10%.<xref ref-type="bibr" rid="article-28074.r4">[4]</xref></p>
      </sec>
      <sec id="article-28074.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Electrophysiological mechanisms of pulseless ventricular tachycardia are increased automaticity and triggered activity. Electrical impulses originating in ventricular myocardium spread through ischemic myocardium or scar tissue resulting in retrograde atria activation or AV dissociation.</p>
        <p>In pulseless ventricular tachycardia, the ventricles contract at a rate too rapid to allow for an adequate filling time during diastole, subsequently resulting in hemodynamic collapse from a diminished cardiac output&#x000a0;causing&#x000a0;insufficient blood supply to end organs.&#x000a0;Abnormal ventricular conduction and asynchrony further reduce the effectiveness of ventricular contractions and aggravate the hemodynamics, leading to sudden collapse.&#x000a0;There are two main types of ventricular tachycardia with the morphology of the QRS complexes serving as clues to the cause responsible for the rhythm.</p>
        <p>In monomorphic ventricular tachycardia, which is more common, the QRS complexes are identical because there is increased automaticity originating from a single focus in either of the ventricles or a re-entry circuit within the ventricle. The most common cause for monomorphic ventricular tachycardia is scarring of the myocardium from myocardial infarction, which promotes the development of an electrical circuit around the non-conducting fibrotic tissue resulting in the&#x000a0;formation of multiple circuits that potentially can evolve into a re-entrant ventricular tachyarrhythmia.<xref ref-type="bibr" rid="article-28074.r5">[5]</xref></p>
        <p>In polymorphic ventricular tachycardia, the QRS complexes vary in morphology and usually result from inherent genetic mutations that disrupt&#x000a0;the ion channel&#x000a0;function of cardiac myocytes and cause electrophysiological abnormalities during ventricular repolarization.<xref ref-type="bibr" rid="article-28074.r6">[6]</xref> Congenital conditions predisposing to polymorphic ventricular tachycardia usually exhibit&#x000a0;prolongation of the QT interval on the EKG. Acquired etiologies that may lead to the development of polymorphic ventricular tachycardia also include drug toxicity of antiarrhythmic drugs, antibiotics, and antipsychotic medications that prolong the QT interval.</p>
      </sec>
      <sec id="article-28074.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Before the event, patients with pulseless ventricular tachycardia may complain of chest pain, palpitations, dyspnea, light-headedness, and syncope. On physical examination, there will be signs of impaired perfusion, hypotension, tachypnea, elevated jugular venous pressure, and S1 heart sound. Sudden collapse results from ineffective ventricular contractions and low cardiac output.</p>
        <p>At the time of the event, patients with pulseless ventricular tachycardia are unconscious and unresponsive without a palpable pulse. Any delay in starting defibrillation dramatically reduces survival, and death may occur in a few minutes.</p>
      </sec>
      <sec id="article-28074.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of pulseless VT is based on physical examination and ECG. Cardiopulmonary resuscitation, according to Advanced Cardiac Life Support guidelines, should be started immediately as far as the diagnosis is confirmed. ECG findings usually include regular R-R intervals, rapid ventricular rate with an undistinguishable atrial rate (absence of p-waves), AV dissociation, and a wide QRS complex (more than 0.12 sec).<xref ref-type="bibr" rid="article-28074.r7">[7]</xref></p>
        <p>Several ECG criteria have been created to help diagnose VT.<xref ref-type="bibr" rid="article-28074.r8">[8]</xref>&#x000a0;These criteria include:</p>
        <p>
<bold>The Classical Criteria:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>AV dissociation</p>
          </list-item>
          <list-item>
            <p>Capture or fusion beats</p>
          </list-item>
          <list-item>
            <p>Negative or positive concordance&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Right bundle branch configuration
<list list-type="bullet"><list-item><p>QRS width &#x0003e;140 ms and left axis&#x000a0;</p></list-item><list-item><p>QR, R, or RSr' complex in V1</p></list-item><list-item><p>RS &#x0003e;1 in V6 or QS in V6</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Left bundle branch configuration
<list list-type="bullet"><list-item><p>QRS width &#x0003e;160 ms and right axis</p></list-item><list-item><p>Initial R in V1 &#x0003e;30 ms</p></list-item><list-item><p>Slurring or notching of the downstroke of the S-wave in V1-2</p></list-item><list-item><p>Begin QRS-nadir S-wave in V1-2</p></list-item><list-item><p>Any Q in V6</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Brugada Criteria:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Absence of an RS complex in all precordial leads</p>
          </list-item>
          <list-item>
            <p>The longest R to S interval &#x0003e;100 ms in any precordial lead</p>
          </list-item>
          <list-item>
            <p>AV dissociation</p>
          </list-item>
          <list-item>
            <p>Classical criteria for both VT present in both lead V1-2 and V6</p>
          </list-item>
        </list>
        <p>If&#x000a0;any single one of the above Brugada criteria is present, then VT is diagnosed.</p>
        <p>
<bold>The Vereckei Criteria:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The presence of AV dissociation</p>
          </list-item>
          <list-item>
            <p>In lead aVR (any one of the following):
<list list-type="bullet"><list-item><p>The presence of an initial R-wave</p></list-item><list-item><p>Initial R or Q &#x0003e; 40ms</p></list-item><list-item><p>Notch in the descending limb of a negative onset and predominantly negative QRS</p></list-item><list-item><p>Vi/Vt&#x000a0;&#x02264; 1</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>In general, per the AHA, basic criteria to support the diagnosis of VT includes <xref ref-type="bibr" rid="article-28074.r9">[9]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>AV dissociation&#x000a0;</p>
          </list-item>
          <list-item>
            <p>QRS complex &#x0003e;0.14 seconds</p>
          </list-item>
          <list-item>
            <p>Monophasic R wave in aVR</p>
          </list-item>
          <list-item>
            <p>Specific QRS morphologies (i.e., positively or negatively concordant QRS complex in precordial leads)</p>
          </list-item>
          <list-item>
            <p>The absence of an RS complex in all precordial leads</p>
          </list-item>
          <list-item>
            <p>An RS interval &#x0003e;100 ms in at least 1 precordial lead</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28074.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Pulseless ventricular tachycardia is a medical emergency, and its management should follow advanced life support guidelines.<xref ref-type="bibr" rid="article-28074.r7">[7]</xref>&#x000a0;Pulseless VT requires immediate electrical cardioversion with high-energy defibrillator (150-200 J on biphasic and 360 J on monophasic).<xref ref-type="bibr" rid="article-28074.r10">[10]</xref>&#x000a0;Delaying defibrillation for 2 minutes or more decrease survival rate compared with patients received immediate defibrillation (39,3% vs. 22,2%).<xref ref-type="bibr" rid="article-28074.r11">[11]</xref></p>
        <p>In a series of shocks, each following shock should be higher in energy than the previous shock. After the first shock delivered, 5 cycles of CPR should be performed. Each CPR cycle should contain 30 chest compressions followed by 2 breaths.<xref ref-type="bibr" rid="article-28074.r11">[11]</xref><xref ref-type="bibr" rid="article-28074.r7">[7]</xref>&#x000a0;Cardiopulmonary resuscitation is performed only until the defibrillator is ready. Defibrillation requires fewer joules if it is done early. After every shock, chest compressions should be performed, along with oxygen delivery and intravenous injection of vasopressors and antiarrhythmic drugs.<xref ref-type="bibr" rid="article-28074.r7">[7]</xref><xref ref-type="bibr" rid="article-28074.r12">[12]</xref></p>
        <p>After the conversion to sinus rhythm, the patient should be monitored continuously. Metabolic acidosis quickly follows cardiovascular collapse. If the arrhythmia is terminated within 30&#x000a0;to 60 seconds, significant acidosis does not occur. If a patient is unresponsive after return to a normal rhythm or the event happened out-of-hospital, hypothermia cooling to 32-34 degrees Celcius for 24 hours should be initiated for possible neurologic recovery.<xref ref-type="bibr" rid="article-28074.r7">[7]</xref></p>
        <p>In every case of pulseless VT acute myocardial infarction should be suspected and urgent coronary angiography and PCI should be considered if feasible.<xref ref-type="bibr" rid="article-28074.r10">[10]</xref><xref ref-type="bibr" rid="article-28074.r13">[13]</xref>&#x000a0;Fibrinolytic therapy during CPR for pulseless VT is not recommended.</p>
        <p>Medical treatment of pulseless VT usually is carried out along with defibrillation and includes intravenous vasopressors and antiarrhythmic drugs. 1 mg of epinephrine IV should be given every 3 to 5 minutes. Epinephrine can be replaced by vasopressin given 40 units IV once.<xref ref-type="bibr" rid="article-28074.r14">[14]</xref>&#x000a0;Amiodarone is the most studied drug and is used for the prevention of sudden cardiac death (SCD). Sotalol is the most widely used alternative but is associated with an increased risk of SCD due to decreasing defibrillation threshold. Patients on beta-blockers reported having lower mortality rates.</p>
        <p>For primary prevention of SCD in patients from the high-risk group, as well as for secondary prevention in patients who already have a prior history of sustained VT or VF, ICD implantation is recommended.<xref ref-type="bibr" rid="article-28074.r15">[15]</xref><xref ref-type="bibr" rid="article-28074.r16">[16]</xref>&#x000a0;Implantable cardiac defibrillators (ICDs) have benefits in terms of mortality and survival rates compared to medical treatment.</p>
      </sec>
      <sec id="article-28074.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The following signs speak in favor of ventricular tachycardia: QRS complex greater than 0.14 seconds with right bundle branch morphology or greater than 0.16 seconds with left bundle branch morphology, RS interval &#x0003e; 100 ms in a precordial lead, AV dissociation, negative QRS concordance in the precordial leads and ventricular fusion beats.<xref ref-type="bibr" rid="article-28074.r12">[12]</xref></p>
        <p>If the patient&#x02019;s condition allows, differential diagnosis of a wide-complex tachycardia should be made between ventricular tachycardia (80% of wide-QRS tachycardia cases), supraventricular tachycardia (SVT) with aberrant conduction (15% to 20%) and SVT with pre-excitation and antidromic atrioventricular reentrant tachycardia (AVRT) (1% to 5%).<xref ref-type="bibr" rid="article-28074.r16">[16]</xref> Every wide complex tachycardia should be considered as VT until proven otherwise.<xref ref-type="bibr" rid="article-28074.r17">[17]</xref><xref ref-type="bibr" rid="article-28074.r18">[18]</xref></p>
      </sec>
      <sec id="article-28074.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis of pulseless ventricular tachycardia heavily depends on the time from the onset of tachycardia to defibrillation and restoration of sinus rhythm and efficient perfusion. Shorter delays in defibrillation associated with higher survival rates, up to 50%. Delays in treatment up to 15 minutes decrease the survival rates to as low as 5%.<xref ref-type="bibr" rid="article-28074.r18">[18]</xref> The prognosis also depends on a patient's cardiac status, including underlying ischemic or structural heart disease, as well as other comorbidities.</p>
      </sec>
      <sec id="article-28074.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Pusless ventricular tachycardia can lead to cardiac arrest and insufficient organ perfusion, which is the main cause of most complications. Anoxic brain injury and lifelong neurological complications can result from&#x000a0;tachycardia that lasts for greater than 3 minutes.<xref ref-type="bibr" rid="article-28074.r19">[19]</xref> Anoxic brain injury is one of the multiple pathophysiological conditions that can occur in post-cardiac arrest syndrome.</p>
        <p>Other&#x000a0;complications of the post-cardiac arrest syndrome include post-cardiac arrest myocardial dysfunction and systemic ischemia/reperfusion response. Myocardial dysfunction from ischemia can lead to transient global dysfunction and is a common cause of early mortality after cardiac arrest.<xref ref-type="bibr" rid="article-28074.r20">[20]</xref> Reperfusion after ischemia causes activation of immunologic and coagulation pathways, which increases the risk of multiple organ failure and infections. The ischemic-reperfusion injury also depletes intravascular volume and impairs vasoregulation and oxygen delivery to organ tissues.<xref ref-type="bibr" rid="article-28074.r20">[20]</xref> Treatment for post-cardiac arrest syndrome includes multiple areas of treatment measures, including hemodynamic monitoring, airway management, and neurological assessments.</p>
      </sec>
      <sec id="article-28074.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Pulseless ventricular tachycardia&#x000a0;is most commonly due to cardiac ischemia. Patients with ischemic heart disease&#x000a0;should be educated on lifestyle changes such as low cholesterol and low salt diet and regular exercise. Patients who smoke should be&#x000a0;encouraged to quit smoking. Patients should be sure to establish with a cardiologist for follow up and for proper medical management to ensure the underlying cause is being properly treated and to prevent reoccurrence. In patients where the cause of ventricular tachycardia was due to medication side effects, proper medication education for all patients is essential.</p>
      </sec>
      <sec id="article-28074.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>
<bold>Pearls and Key Issues</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Pulseless VT is a medical emergency that requires immediate defibrillation.</p>
          </list-item>
          <list-item>
            <p>The energy of 150-200 J on biphasic and 360 J on monophasic defibrillator should be used.</p>
          </list-item>
          <list-item>
            <p>Delaying defibrillation of pulseless VT dramatically decreases the survival rate.</p>
          </list-item>
          <list-item>
            <p>Critical interventions in the post-arrest phase are coronary angiography and PCI.</p>
          </list-item>
          <list-item>
            <p>Implantation of ICD is indicated both for primary and secondary prevention of VT/V-fib.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28074.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Pulseless ventricular tachycardia is a life-threatening arrhythmia. Early recognition and prompt cardiopulmonary resuscitation with defibrillation can be life-saving and may also prevent lifelong complications. Interprofessional healthcare teams usually include nurses, physicians, mid-level providers, anesthesia, respiratory therapists and pharmacists. Effective communication between&#x000a0;all members of the healthcare team&#x000a0;is essential for early initiation of life-saving measures in patients who develop pulseless ventricular tachycardia. Each minute in treatment delay decreases the chance of survival by approximately 10%.<xref ref-type="bibr" rid="article-28074.r21">[21]</xref>&#x000a0;Continuing medical education keeps providers and medical staff up to date on The American Heart Association ACLS protocol, and all healthcare team members need to be certified and remain current. In persons who recover, prompt evaluation by a cardiologist is essential for the prevention of recurrent arrhythmias and complications. [Level 1]</p>
        <p>A board-certified cardiology pharmacist will play a vital role in these cases, given the nature of the drugs involved. They will consult with the cardiology team on agent selection, appropriate dosing, check for interactions, and provide direction to nursing staff on adverse events. Nursing will monitor the patient after assisting in the emergency procedures upon arrival at the healthcare facility. These interprofessional actions will increase survival in cases of pulseless VT. [Level 5]</p>
        <p>Bystander CPR and public access to a defibrillator have helped increase the survival rate of out of hospital cardiac arrest, although survival remains under 10%.<xref ref-type="bibr" rid="article-28074.r22">[22]</xref>&#x000a0;Once the patient has arrived at the hospital, temperature control, and cardio-cerebral resuscitation measure further improve overall survival.<xref ref-type="bibr" rid="article-28074.r22">[22]</xref>&#x000a0;[Level 1]&#x000a0;</p>
        <p>Regardless of the location, early recognition and prompt initiation of advanced cardiac life support protocol are crucial elements to survival.</p>
      </sec>
      <sec id="article-28074.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28074&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28074">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/pulseless-ventricular-tachycardia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28074">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28074/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28074">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-28074.s16">
        <fig id="article-28074.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Ventricular Tachycardia rhythm example Contributed by Tammy J. Toney-Butler, AS, RN, CEN, TCRN, CPEN</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Ventricular__Tachycardia" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-28074.s17">
        <fig id="article-28074.image.f2" position="float" orientation="portrait">
          <caption>
            <p>This is a classic 12 lead EKG of a patient with Torsade de Pointes. It shows the polymorphic nature of the tachycardia, the long QT interval and the initiation of the tachycardia with a late coupled P.V.C. Contributed by Michael Rosengarten BEng, MD.McGill (CC BY-SA 3.0 https://creativecommons.org/licenses/by-sa/3.0/deed.en)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="112_xCardioNetworks_ECGpediax" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-28074.s18">
        <title>References</title>
        <ref id="article-28074.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baldzizhar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Manuylova</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Marchenko</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kryvalap</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Carey</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Ventricular Tachycardias: Characteristics and Management.</article-title>
            <source>Crit Care Nurs Clin North Am</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>317</fpage>
            <page-range>317-29</page-range>
            <pub-id pub-id-type="pmid">27484660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tang</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Shenasa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boyle</surname>
                <given-names>NG</given-names>
              </name>
            </person-group>
            <article-title>Ventricular Arrhythmias and Sudden Cardiac Death.</article-title>
            <source>Card Electrophysiol Clin</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>693</fpage>
            <page-range>693-708</page-range>
            <pub-id pub-id-type="pmid">29173411</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McNally</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Robb</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vellano</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Valderrama</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Sasson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Crouch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Perez</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Merritt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kellermann</surname>
                <given-names>A</given-names>
              </name>
              <collab>Centers for Disease Control and Prevention</collab>
            </person-group>
            <article-title>Out-of-hospital cardiac arrest surveillance --- Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005--December 31, 2010.</article-title>
            <source>MMWR Surveill Summ</source>
            <year>2011</year>
            <month>Jul</month>
            <day>29</day>
            <volume>60</volume>
            <issue>8</issue>
            <fpage>1</fpage>
            <page-range>1-19</page-range>
            <pub-id pub-id-type="pmid">21796098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zipes</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Camm</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Borggrefe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buxton</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Chaitman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fromer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gregoratos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moss</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Myerburg</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Priori</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Quinones</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Roden</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Silka</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Tracy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Blanc</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Budaj</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dean</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Deckers</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Despres</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dickstein</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lekakis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McGregor</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Metra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morais</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Osterspey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tamargo</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Zamorano</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Antman</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Halperin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ornato</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Riegel</surname>
                <given-names>B</given-names>
              </name>
              <collab>American College of Cardiology/American Heart Association Task Force</collab>
              <collab>European Society of Cardiology Committee for Practice Guidelines</collab>
              <collab>European Heart Rhythm Association and the Heart Rhythm Society</collab>
            </person-group>
            <article-title>ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.</article-title>
            <source>Eur Heart J</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>27</volume>
            <issue>17</issue>
            <fpage>2099</fpage>
            <page-range>2099-140</page-range>
            <pub-id pub-id-type="pmid">16923744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>John</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Tedrow</surname>
                <given-names>UB</given-names>
              </name>
              <name>
                <surname>Koplan</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Albert</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Epstein</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Sweeney</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Michaud</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>Ventricular arrhythmias and sudden cardiac death.</article-title>
            <source>Lancet</source>
            <year>2012</year>
            <month>Oct</month>
            <day>27</day>
            <volume>380</volume>
            <issue>9852</issue>
            <fpage>1520</fpage>
            <page-range>1520-9</page-range>
            <pub-id pub-id-type="pmid">23101719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Staikou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chondrogiannis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mani</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Perioperative management of hereditary arrhythmogenic syndromes.</article-title>
            <source>Br J Anaesth</source>
            <year>2012</year>
            <month>May</month>
            <volume>108</volume>
            <issue>5</issue>
            <fpage>730</fpage>
            <page-range>730-44</page-range>
            <pub-id pub-id-type="pmid">22499746</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neumar</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Shuster</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Callaway</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Gent</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Atkins</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Bhanji</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Brooks</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>de Caen</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Donnino</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Ferrer</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kleinman</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Kronick</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Lavonas</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Link</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Samson</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Schexnayder</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Singletary</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Sinz</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Travers</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Wyckoff</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Hazinski</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Part 1: Executive Summary: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.</article-title>
            <source>Circulation</source>
            <year>2015</year>
            <month>Nov</month>
            <day>03</day>
            <volume>132</volume>
            <issue>18 Suppl 2</issue>
            <fpage>S315</fpage>
            <page-range>S315-67</page-range>
            <pub-id pub-id-type="pmid">26472989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alzand</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Crijns</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic criteria of broad QRS complex tachycardia: decades of evolution.</article-title>
            <source>Europace</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>465</fpage>
            <page-range>465-72</page-range>
            <pub-id pub-id-type="pmid">21131372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalia</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Essandoh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cronin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gerstein</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Schulman</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A Narrative Review for Anesthesiologists of the 2017 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.</article-title>
            <source>J Cardiothorac Vasc Anesth</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>1722</fpage>
            <page-range>1722-1730</page-range>
            <pub-id pub-id-type="pmid">30685157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <collab>International Liaison Committee on Resuscitation</collab>
            <article-title>2005 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Part 8: Interdisciplinary topics.</article-title>
            <source>Resuscitation</source>
            <year>2005</year>
            <season>Nov-Dec</season>
            <volume>67</volume>
            <issue>2-3</issue>
            <fpage>305</fpage>
            <page-range>305-14</page-range>
            <pub-id pub-id-type="pmid">16324994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Krumholz</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Nichol</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nallamothu</surname>
                <given-names>BK</given-names>
              </name>
              <collab>American Heart Association National Registry of Cardiopulmonary Resuscitation Investigators</collab>
            </person-group>
            <article-title>Delayed time to defibrillation after in-hospital cardiac arrest.</article-title>
            <source>N Engl J Med</source>
            <year>2008</year>
            <month>Jan</month>
            <day>03</day>
            <volume>358</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-17</page-range>
            <pub-id pub-id-type="pmid">18172170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perkins</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Handley</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Koster</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Castr&#x000e9;n</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Smyth</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Olasveengen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Monsieurs</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Raffay</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gr&#x000e4;sner</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Wenzel</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ristagno</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Soar</surname>
                <given-names>J</given-names>
              </name>
              <collab>Adult basic life support and automated external defibrillation section Collaborators</collab>
            </person-group>
            <article-title>European Resuscitation Council Guidelines for Resuscitation 2015: Section 2. Adult basic life support and automated external defibrillation.</article-title>
            <source>Resuscitation</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>95</volume>
            <fpage>81</fpage>
            <page-range>81-99</page-range>
            <pub-id pub-id-type="pmid">26477420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kolh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Windecker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alfonso</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Collet</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Cremer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Falk</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Filippatos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hamm</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Head</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>J&#x000fc;ni</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kappetein</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Kastrati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Knuuti</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Landmesser</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Laufer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Richter</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Schauerte</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sousa Uva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stefanini</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Taggart</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Torracca</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Valgimigli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wijns</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Witkowski</surname>
                <given-names>A</given-names>
              </name>
              <collab>European Society of Cardiology Committee for Practice Guidelines</collab>
              <name>
                <surname>Zamorano</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Achenbach</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bax</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Bueno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dean</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Deaton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Erol</surname>
                <given-names>&#x000c7;</given-names>
              </name>
              <name>
                <surname>Fagard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hasdai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hoes</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Kirchhof</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Knuuti</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kolh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lancellotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Linhart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nihoyannopoulos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Piepoli</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Ponikowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sirnes</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Tamargo</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Tendera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Torbicki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wijns</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Windecker</surname>
                <given-names>S</given-names>
              </name>
              <collab>EACTS Clinical Guidelines Committee</collab>
              <name>
                <surname>Sousa Uva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Achenbach</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pepper</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Anyanwu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Badimon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bauersachs</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Baumbach</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Beygui</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bonaros</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>De Carlo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Deaton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dobrev</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dunning</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Eeckhout</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gielen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hasdai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kirchhof</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Luckraz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mahrholdt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Montalescot</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Paparella</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rastan</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Sanmartin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sergeant</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Silber</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tamargo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>ten Berg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thiele</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>van Geuns</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>HO</given-names>
              </name>
              <name>
                <surname>Wassmann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wendler</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Zamorano</surname>
                <given-names>JL</given-names>
              </name>
              <collab>Task Force on Myocardial Revascularization of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery</collab>
              <collab>European Association of Percutaneous Cardiovascular Interventions</collab>
            </person-group>
            <article-title>2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).</article-title>
            <source>Eur J Cardiothorac Surg</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>517</fpage>
            <page-range>517-92</page-range>
            <pub-id pub-id-type="pmid">25173601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>European Heart Rhythm Association</collab>
              <collab>Heart Rhythm Society</collab>
              <name>
                <surname>Fuster</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ryd&#x000e9;n</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Cannom</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Crijns</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Ellenbogen</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Halperin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Le Heuzey</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Kay</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Olsson</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Prystowsky</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Tamargo</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Wann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Antman</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ornato</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Riegel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Priori</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Blanc</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Budaj</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Camm</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Dean</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Deckers</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Despres</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dickstein</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lekakis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McGregor</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Metra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morais</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Osterspey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zamorano</surname>
                <given-names>JL</given-names>
              </name>
              <collab>American College of Cardiology</collab>
              <collab>American Heart Association Task Force on Practice Guidelines</collab>
              <collab>European Society of Cardiology Committee for Practice Guidelines</collab>
              <collab>Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation</collab>
            </person-group>
            <article-title>ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2006</year>
            <month>Aug</month>
            <day>15</day>
            <volume>48</volume>
            <issue>4</issue>
            <fpage>854</fpage>
            <page-range>854-906</page-range>
            <pub-id pub-id-type="pmid">16904574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Callaway</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>Epinephrine for cardiac arrest.</article-title>
            <source>Curr Opin Cardiol</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-42</page-range>
            <pub-id pub-id-type="pmid">23196774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kusumoto</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Chaouki</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Deshmukh</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Gautam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Lambrakos</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Nasser</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Sorajja</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Systematic review for the 2017&#x000a0;AHA/ACC/HRS guideline for management of patients with ventricular&#x000a0;arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.</article-title>
            <source>Heart Rhythm</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>10</issue>
            <fpage>e253</fpage>
            <page-range>e253-e274</page-range>
            <pub-id pub-id-type="pmid">29097318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brugada</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Brugada</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mont</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Smeets</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Andries</surname>
                <given-names>EW</given-names>
              </name>
            </person-group>
            <article-title>A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex.</article-title>
            <source>Circulation</source>
            <year>1991</year>
            <month>May</month>
            <volume>83</volume>
            <issue>5</issue>
            <fpage>1649</fpage>
            <page-range>1649-59</page-range>
            <pub-id pub-id-type="pmid">2022022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holmberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Holmberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Herlitz</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Incidence, duration and survival of ventricular fibrillation in out-of-hospital cardiac arrest patients in sweden.</article-title>
            <source>Resuscitation</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-17</page-range>
            <pub-id pub-id-type="pmid">10699695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kang</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Huh</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>WY</given-names>
              </name>
            </person-group>
            <article-title>Association Between Time to Defibrillation and Neurologic Outcome in Patients With In-Hospital Cardiac Arrest.</article-title>
            <source>Am J Med Sci</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>358</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-148</page-range>
            <pub-id pub-id-type="pmid">31200920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kang</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Management of post-cardiac arrest syndrome.</article-title>
            <source>Acute Crit Care</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>173</fpage>
            <page-range>173-178</page-range>
            <pub-id pub-id-type="pmid">31723926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ali</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zafari</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Narrative review: cardiopulmonary resuscitation and emergency cardiovascular care: review of the current guidelines.</article-title>
            <source>Ann Intern Med</source>
            <year>2007</year>
            <month>Aug</month>
            <day>07</day>
            <volume>147</volume>
            <issue>3</issue>
            <fpage>171</fpage>
            <page-range>171-9</page-range>
            <pub-id pub-id-type="pmid">17679705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28074.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Diepen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Girotra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Abella</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Bobrow</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Fahrenbruch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Granger</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Jollis</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>McNally</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yannopoulos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rea</surname>
                <given-names>TD</given-names>
              </name>
            </person-group>
            <article-title>Multistate 5-Year Initiative to Improve Care for Out-of-Hospital Cardiac Arrest: Primary Results From the HeartRescue Project.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2017</year>
            <month>Sep</month>
            <day>22</day>
            <volume>6</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">28939711</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
